ACE and focal segmental glomerulosclerosis: However, the inclusion of other indicators such as medication (e.g., ACE inhibitors/ARBs, non-corticosteroid immunomodulators) and health care utilization (e.g., frequency of outpatient visits and hospitalization) may also be useful in risk stratification for more appropriate and timely management of FSGS.